Cytokinetics | CYTK - Operating Expenses


Cytokinetics reported $168.69M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 242.88M 10.68M Sep/2025
Amgen USD 5.13B 1.39B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
Bristol-Myers Squibb USD 18.55B 10.06B Sep/2025
Cytokinetics USD 168.69M 9.58M Sep/2025
Eisai JPY 183.69B 1.78B Sep/2025
Eli Lilly USD 9.21B 677.8M Sep/2025
Exelixis USD 341.4M 13.29M Sep/2025
Geron USD 61.11M 376K Sep/2025
Halozyme Therapeutics USD 136.34M 13.06M Sep/2025
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
Ligand Pharmaceuticals USD 8.29M 32.17M Sep/2025
Merck USD 10.72B 1.28B Sep/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 92.8B 82.47B Sep/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025